Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.
Qkine wins 'Scale-up of the Year' at the 2024 Cambridge Independent Business Awards On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the [...]
This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.
Qkine is pleased to announce a new global sales distribution agreement with AI driven digital research platform Scientist.com on their Product Hub Marketplace.
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science [...]
Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support
Qkine is a company run by scientists, and the science is the focus of everything we do.Our theme at ISSCR this year was stress-free stem cell culture - exploring how suppliers of recombinant proteins can proactively improve the quality, availability and functionality of growth factors to generate experimental outcomes faster, easier and more efficiently.We discussed priorities for the stem cell science supply chain with scientists from academic and industry labs and had in-depth conversations about the impact of growth factors and cytokines quality on reproducibility and how to integrate new technologies, such as controlled-release and thermostable proteins, to improve the scalability of expansion and differentiation protocols.Through collaboration, we learn and, together, improve the future of stem cell research.
Reflections on the dynamic ISSCR 2024 workshop on Standards for Human Stem Cell Use in Research including recommendations for growth factor supply chains for raw (ancillary materials) for cell therapy and ATMP manufacture.
Commercial sources of recombinant human GDF15 protein, in particular those purified from mammalian expression, are frequently contaminated with trace amounts of TGFβ and related proteins. These trace contaminants cause misleading experimental results due to the picomolar or even femtomolar EC50s of this family of cytokines. Please be cautious with your source of recombinant GDF15 protein.
Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
